New CDK Inhibitors

HomeNew CDK Inhibitors
Catalog No. Product Name Information
F0536 p14 ARF Antibody [J3P11] CDKN2A/p14ARF,p14 ARF,p14ARF,p14ARF/CDKN2A
F0549 NFAT1 Antibody [G21N1] NFAT1,NFATC2,NFATC2/NFAT1
F0460 p35/25 Antibody [H17P2]
E6400 BSJ-5-63 BSJ-5-63 is a potent PROTAC degrader of CDK12, CDK7, CDK9. BSJ-5-63 decreases the protein expression of CDK12, CDK7, CDK9, RNAPII, Cyclin K, while also suppressing the mRNA expression of BRCA1 and BRCA2. BSJ-5-63 demonstrates anticancer properties and has the potential for the research of prostate cancer.
E8310 Ribociclib succinate hydrate Ribociclib succinate hydrate is an orally bioavailable and selective, inhibitor of both CDK4 and CDK6 with IC50 values of 10 nM and 39 nM, respectively. It exhibits anticancer activitiy and can be used in breast cancer, melanoma, liposarcoma, non–small cell lung cancer, and neuroblastoma therapy research.
≡ All CDK Inhibitors